Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
Work
Year: 2010
Type: article
Abstract: The Janus kinase (JAK) family of tyrosine kinases includes JAK1, JAK2, JAK3 and TYK2, and is required for signaling through Type I and Type II cytokine receptors. CP-690,550 is a potent and selective ... more
Source: Journal of Inflammation
Authors Debra M. Meyer, Michael I. Jesson, Xiong Li, Mollisa M. Elrick, Christie L. Funckes-Shippy +9 more
Institution Pfizer (United States)
Cites: 44
Cited by: 441
Related to: 10
FWCI: 11.9
Citation percentile (by year/subfield): 99.99
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,318